Gustavo Mahler, PhD, joined CMC Biologics in 2008 as president. In 2010, he was named global Chief Operations Officer and in January, 2016 he became Chief Executive Officer. Prior to joining CMC Biologics, Gustavo worked for 15 years at Bayer in the United States, Europe and Latin America serving in various manufacturing and general management positions. He received his PhD in Biochemistry from the University of Buenos Aires, and he also has a Master of Business Administration degree from the University UNED of Madrid and an Executive Certification in Management from MIT Sloan.
Robert (Bob) Broeze joined CMC Biologics in 2015 and serves as the Chief Business Officer, responsible for global sales and marketing. He has over 30 years of experience in the biopharmaceutical and contract manufacturing industries including positions as Senior VP, Business Development at Gallus Biopharmaceuticals, LLC (now Patheon Biologics) and Chief Commercial Officer and Chief Executive Officer at Laureate BioPharma. His technical expertise spans research, development, protein characterization, validation, testing and cGMP manufacture of biopharmaceutical products, from pilot to Phase III clinical and commercial scale with a strong emphasis on monoclonal antibody products for therapeutic and diagnostic use. He also held senior positions in R&D and operations at Purdue BioPharma L.P., Bard BioPharma L.P and at Cytogen Corporation. Bob is a graduate of Rensselaer Polytechnic Institute where he earned his BS and PhD degrees.
Patricio Massera joined CMC Biologics in August 2012 as General Manager and Managing Director of the CMC Biologics A/S based in Copenhagen. He has been working in Biologics for the last 20 years. Along his career, Patricio has covered several key executive positions at MSD AH, Intervet/Schering-Plough, Biogenesis-Bagó and other Biotech companies in Spain, Brazil and Argentina developing, manufacturing and controlling biotechnological products and vaccines for human health and animal health. He led a staff of more than 250 employees operating in continues large scale manufacturing facilities. He has acted as change agent in several integration processes and developed strong leadership teams. Patricio holds Biochemist degree from University of Buenos Aires and a Master in Business Administration from UCEMA.
SoYoung Kwon joined CMC Biologics in 2015 as Vice President of Legal Affairs. She has over 20 years of experience as a corporate attorney and business executive with responsibility for all legal matters, including complex product licensing, research and development, commercial disputes/litigation management, board governance, corporate compliance, HR/Employment, general corporate and transactional matters. Ms. Kwon has served as primary counsel to the board, and all board committees and has partnered with management and business leaders to achieve business initiatives. SoYoung holds a Juris Doctorate from Willamette University College of Law and a Masters of Law in Asian and Comparative Law from the University of Washington School of Law.
Paul joined CMC Biologics in 2015 as vice president for the quality unit. He has over 25 years of experience in development of protein and small molecule products. Prior to CMC Biologics, he held positions of increasing responsibilities at Amgen and Eli Lilly in operations, quality and analytical development. Paul has a PhD in Chemistry from Texas A&M University and a Bachelor of Science in Applied Chemistry from Harvey Mudd College.